Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for Treatment-Resistant Depression
NCT03932825Phase 2Completed
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nitrous oxide in treatment-resistant depression (TRD) (2 arms). Primary endpoints: Hamilton Depression Rating Scale-17 item at 2 weeks, Quick Inventory of Depressive Symptomatology-16 Self Report at 2 weeks and 1 more. Started Apr 2019; status: completed.
02
Drugs
nitrous oxide
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT03932825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932825.